眼压负荷试验识别诊室眼压控制下仍快速进展的青光眼
前瞻性队列研究纳入67眼(36例)青光眼患者,采用标准化饮水试验作为眼压负荷试验,随访2.2±1.0年。在诊室眼压达标的59眼中,饮水试验峰值眼压>21 mmHg的22眼(37%)平均偏差下降和视网膜神经纤维层变薄速度显著更快。快速进展眼多数诊室眼压达标,但饮水试验峰值多超过21 mmHg,提示该试验可提供常规眼压测量之外的补充风险信息。
要点
- 诊室眼压达标的青光眼中,饮水试验峰值眼压>21 mmHg者视野和结构进展更快。
- 快速进展眼多数诊室眼压达标,仅23%高于目标眼压,而77%饮水试验峰值>21 mmHg。
- 饮水试验峰值眼压与进展的关联经诊室眼压校正后仍显著,提供补充预后信息。
核心结论
- 眼压负荷试验与青光眼功能及结构进展更快相关,可在诊室眼压看似达标的眼中识别更高风险眼。
- 饮水试验峰值眼压>21 mmHg提供独立于诊室眼压的补充风险信息。
研究设计与样本
- 前瞻性队列研究,纳入67眼(36例)青光眼患者,行标准化饮水试验作为眼压负荷试验。
- 基线和随访终点各进行5次密集访视(视野和SD-OCT),其间每6个月单次访视,平均随访2.2±1.0年,每眼平均14±5次检查。
主要发现
- 诊室眼压达标的59眼中,22眼(37%)饮水试验峰值眼压>21 mmHg,其平均偏差变化为-0.67 vs +0.16 dB/y(P=.009),RNFL变薄为-0.74 vs -0.18 µm/y(P=.002)。
- 13眼(19%)被归类为快速进展眼,其中仅3眼(23%)诊室眼压高于目标,而10眼(77%)饮水试验峰值眼压>21 mmHg。
- 多因素模型校正诊室眼压后,饮水试验峰值眼压>21 mmHg仍与平均偏差变化(β=-0.659 dB/y,P=.006)和RNFL变化(β=-0.467 µm/y,P=.035)显著相关。
关键数值与推荐
- 饮水试验峰值眼压>21 mmHg作为负荷试验阳性阈值。
- 诊室眼压控制按严重程度特异性目标眼压评估。
临床怎么用
- 对诊室眼压达标但仍有进展迹象的青光眼,可考虑饮水试验辅助识别快速进展高风险眼。
- 饮水试验峰值眼压>21 mmHg提示需加强监测或调整治疗,即使诊室眼压已在目标范围。
局限性
- 样本量较小(67眼、36例),随访2.2±1.0年。
- 原文未报告饮水试验的具体操作方案细节。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To evaluate whether an intraocular pressure (IOP) stress test can identify glaucoma eyes at risk for faster functional and structural progression despite apparently controlled office IOP. DESIGN: Prospective cohort study. PARTICIPANTS: Sixty-seven eyes of 36 participants with glaucoma. METHODS: Participants underwent a standardized water-drinking test (WDT) as an IOP stress test. Visual field and spectral-domain optical coherence tomography testing were obtained in clusters (five visits) at baseline and end of follow-up, with interim single visits every 6 months between clusters. Rates of mean deviation (MD) change and retinal nerve fiber layer (RNFL) thinning were estimated by ordinary least-squares regression. Associations between WDT-derived IOP parameters and rates of change were assessed, including analyses stratified by severity-specific target IOP. Multivariable generalized estimating equation models evaluated WDT peak IOP and its association with progression after adjustment for office IOP and clinical covariates. MAIN OUTCOME MEASURES: Rates of MD change and global RNFL thinning over time. RESULTS: Mean follow-up after the WDT was 2.2 ± 1.0 years, with a mean of 14 ± 5 testing visits per eye. Among 59 eyes whose office IOP was within severity-specific target, 22 (37%) had WDT peak IOP > 21 mm Hg and showed significantly faster rate of MD loss (-0.67 vs +0.16 dB/y, P = .009) and RNFL thinning (-0.74 vs -0.18 µm/y, P = .002) than the remaining office-controlled eyes. Thirteen eyes (19%) were classified as fast progressors. Most rapidly progressing eyes would have been considered adequately controlled by office tonometry, with only 3 of 13 (23%) above target, whereas the WDT peak exceeded 21 mm Hg in 10 of 13 (77%). In multivariable models, WDT peak IOP > 21 mm Hg remained significantly associated with faster MD change (β = -0.659 dB/y, P = .006) and RNFL change (β = -0.467 µm/y, P = .035) after adjustment for office IOP, indicating complementary prognostic information; results were similar when WDT peak and office IOP were modeled continuously or symmetrically. CONCLUSIONS: IOP stress testing was associated with faster functional and structural glaucoma progression and identified higher risk eyes among those with apparently controlled office IOP, providing risk information complementary to routine office tonometry.
引用
- Malek DA, Medeiros FA. Intraocular Pressure Stress Testing Identifies Glaucoma Eyes at Risk of Fast Progression Despite Controlled Office Pressure. Am J Ophthalmol. 2026. PMID: 42586188. doi:10.1016/j.ajo.2026.08.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。